The low chamber pancreatic cancer cells had stem-like characteristics in modified transwell system: Is it a novel method to identify and enrich cancer stem-like cells?

BioMed Research International

Volumn 2014, Issue , 2014, Pages

  Wang, Dongqing ^a   Zhu, Haitao ^a   Liu, Yanfang ^a   Liu, Qing ^a   Xie, Xiaodong ^a   Zhou, Yuepeng ^a   Zhang, Lirong ^a   Zhu, Yan ^a   Zhang, Zhijian ^b   Su, Zhaoliang ^b  

^a AFFILIATED HOSPITAL OF JIANGSU UNIVERSITY   (China)

^b JIANGSU UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CD133 ANTIGEN; CD24 ANTIGEN; CELL ANTIGEN; EPITHELIUM SPECIFIC ANTIGEN; GEMCITABINE; HERMES ANTIGEN; OCTAMER TRANSCRIPTION FACTOR 4; UNCLASSIFIED DRUG; DEOXYCYTIDINE; GLYCOPROTEIN; LEUKOCYTE ANTIGEN; PEPTIDE; TUMOR MARKER;

ANALYTIC METHOD; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER CELL; CANCER CELL CULTURE; CANCER STEM CELL; CARCINOGENICITY; CELL ASSAY; CELL DIFFERENTIATION; CELL ISOLATION; CELL RENEWAL; CELL STRUCTURE; CHEMOSENSITIVITY; CONTROLLED STUDY; EPITHELIAL MESENCHYMAL TRANSITION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MODIFIED TRANSWELL ASSAY; MOUSE; NONHUMAN; PANCREAS CANCER; PROTEIN EXPRESSION; ANALOGS AND DERIVATIVES; ANIMAL; BAGG ALBINO MOUSE; CARCINOGENESIS; CELL COUNT; CELL PROLIFERATION; CELL SURVIVAL; CULTURE TECHNIQUE; DEVICES; DRUG EFFECTS; DRUG RESISTANCE; METABOLISM; MULTICELLULAR SPHEROID; NUDE MOUSE; PANCREAS TUMOR; PATHOLOGY; PROCEDURES; TUMOR CELL LINE; UPREGULATION;

ANIMALS; ANTIGENS, CD; ANTIGENS, CD44; CARCINOGENESIS; CELL COUNT; CELL CULTURE TECHNIQUES; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; DEOXYCYTIDINE; DRUG RESISTANCE, NEOPLASM; EPITHELIAL-MESENCHYMAL TRANSITION; GLYCOPROTEINS; HUMANS; MICE, INBRED BALB C; MICE, NUDE; NEOPLASTIC STEM CELLS; PANCREATIC NEOPLASMS; PEPTIDES; SPHEROIDS, CELLULAR; TUMOR MARKERS, BIOLOGICAL; UP-REGULATION;

EID: 84896260411     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2014/760303     Document Type: Article

References (39)

1. Singh S. K., Hawkins C., Clarke I. D., Squire J. A., Bayani J., Hide T., Henkelman R. M., Cusimano M. D., Dirks P. B., Identification of human brain tumour initiating cells. Nature 2004 432 7015 396 401 2-s2.0-9244241576 10.1038/nature03128 (Pubitemid 39551674)
2. Collins A. T., Berry P. A., Hyde C., Stower M. J., Maitland N. J., Prospective identification of tumorigenic prostate cancer stem cells. Cancer Research 2005 65 23 10946 10951 2-s2.0-28244472369 10.1158/0008-5472.CAN-05-2018 (Pubitemid 41713363)
3. Ricci-Vitiani L., Lombardi D. G., Pilozzi E., Biffoni M., Todaro M., Peschle C., De Maria R., Identification and expansion of human colon-cancer-initiating cells. Nature 2007 445 7123 111 115 2-s2.0-33846095137 10.1038/nature05384 (Pubitemid 46067311)
4. Li C., Heidt D. G., Dalerba P., Burant C. F., Zhang L., Adsay V., Wicha M., Clarke M. F., Simeone D. M., Identification of pancreatic cancer stem cells. Cancer Research 2007 67 3 1030 1037 2-s2.0-33847052127 10.1158/0008-5472.CAN- 06-2030
5. Sampieri K., Fodde R., Cancer stem cells and metastasis. Seminars in Cancer Biology 2012 22 187 193 2-s2.0-84858826809 10.1016/j.semcancer.2012.03. 002
6. Visvader J. E., Lindeman G. J., Cancer stem cells in solid tumours: accumulating evidence and unresolved questions. Nature Reviews Cancer 2008 8 10 755 768 2-s2.0-52549087785 10.1038/nrc2499
7. + prostate cancer cells from xenograft human tumors are enriched in tumorigenic and metastatic progenitor cells. Oncogene 2006 25 12 1696 1708 2-s2.0-33645026803 10.1038/sj.onc.1209327
8. Clay M. R., Tabor M., Owen J. H., Carey T. E., Bradford C. R., Wolf G. T., Wicha M. S., Prince M. E., Single-marker identification of head and neck squamous cell carcinoma cancer stem cells with aldehyde dehydrogenase. Head and Neck 2010 32 9 1195 1201 2-s2.0-77954901231 10.1002/hed.21315
9. Lee J., Kotliarova S., Kotliarov Y., Li A., Su Q., Donin N. M., Pastorino S., Purow B. W., Christopher N., Zhang W., Park J. K., Fine H. A., Tumor stem cells derived from glioblastomas cultured in bFGF and EGF more closely mirror the phenotype and genotype of primary tumors than do serum-cultured cell lines. Cancer Cell 2006 9 5 391 403 2-s2.0-33646358694 10.1016/j.ccr.2006.03.030 (Pubitemid 43668737)
10. + stem-like cells isolated from Panc-1 cell line may contribute to multi-resistance and metastasis of pancreatic cancer. Acta Histochemica 2013 115 4 349 356 10.1016/j.acthis.2012.09.007
11. Na Y. R., Seok S. H., Kim D. J., Han J. H., Kim T. H., Jung H., Lee B. H., Park J. H., Isolation and characterization of spheroid cells from human malignant melanoma cell line WM-266-4. Tumor Biology 2009 30 5-6 300 309 2-s2.0-70450206954 10.1159/000261073
12. Haraguchi N., Utsunomiya T., Inoue H., Tanaka F., Mimori K., Barnard G. F., Mori M., Characterization of a side population of cancer cells from human gastrointestinal system. Stem Cells 2006 24 3 506 513 2-s2.0-33744985294 10.1634/stemcells.2005-0282 (Pubitemid 44464754)
13. Platet N., Mayol J.-F., Berger F., Hérodin F., Wion D., Fluctuation of the SP/non-SP phenotype in the C6 glioma cell line. FEBS Letters 2007 581 7 1435 1440 2-s2.0-33947403202 10.1016/j.febslet.2007.02.071 (Pubitemid 46452620)
14. Shi G.-M., Xu Y., Fan J., Zhou J., Yang X.-R., Qiu S.-J., Liao Y., Wu W.-Z., Ji Y., Ke A.-W., Ding Z.-B., He Y.-Z., Wu B., Yang G.-H., Qin W.-Z., Zhang W., Zhu J., Min Z.-H., Wu Z.-Q., Identification of side population cells in human hepatocellular carcinoma cell lines with stepwise metastatic potentials. Journal of Cancer Research and Clinical Oncology 2008 134 11 1155 1163 2-s2.0-53749088741 10.1007/s00432-008-0407-1
15. Gibbs S., Spiekstra S., Corsini E., McLeod J., Reinders J., Dendritic cell migration assay: a potential prediction model for identification of contact allergens. Toxicology in Vitro 2013 27 3 1170 1179 10.1016/j.tiv.2012.05.016
16. Logsdon C. D., Simeone D. M., Binkley C., Molecular profiling of pancreatic adenocarcinoma and chronic pancreatitis identifies multiple genes differentially regulated in pancreatic cancer. Cancer Research 2003 63 10 2649 2657 (Pubitemid 36605209)
17. Vaccaro V., Bria E., Sperduti I., First-line erlotinib and fixed dose-rate gemcitabine for advanced pancreatic cancer. World Journal of Gastroenterology 2013 19 28 4511 4519 10.3748/wjg.v19.i28.4511
18. + liver cancer stem cells in the hypoxic and nutrient-deprived tumor microenvironment. Cancer Letters 2013 339 1 70 81 10.1016/j.canlet.2013.07.021
19. Saleem A., Jackson A., Mukherjee S., Stones N., Crosby T., Tait D., Price P., Radiotherapy in the management of unresectable locally advanced pancreatic cancer: a survey of the current UK practice of clinical oncologists. Clinical Oncology 2010 22 4 257 260 2-s2.0-77951765458 10.1016/j.clon.2010.02.004
20. Wang J., Zhang W., Sun L., Green tea drinking and risk of pancreatic cancer: a large-scale, population-based case-control study in urban Shanghai. Cancer Epidemiology 2012 36 6 e354 e358
21. Belli C., Cereda S., Anand S., Reni M., Neoadjuvant therapy in resectable pancreatic cancer: a critical review. Cancer Treatment Reviews 2013 39 5 518 524 10.1016/j.ctrv.2012.09.008
22. Fang D., Nguyen T. K., Leishear K., Finko R., Kulp A. N., Hotz S., Van Belle P. A., Xu X., Elder D. E., Herlyn M., A tumorigenic subpopulation with stem cell properties in melanomas. Cancer Research 2005 65 20 9328 9337 2-s2.0-27144557960 10.1158/0008-5472.CAN-05-1343 (Pubitemid 41508000)
23. Hermann P. C., Huber S. L., Herrler T., Aicher A., Ellwart J. W., Guba M., Bruns C. J., Heeschen C., Distinct populations of cancer stem cells determine tumor growth and metastatic activity in human pancreatic cancer. Cell Stem Cell 2007 1 3 313 323 2-s2.0-34548455927 10.1016/j.stem.2007.06.002 (Pubitemid 47355323)
24. Eramo A., Lotti F., Sette G., Pilozzi E., Biffoni M., Di Virgilio A., Conticello C., Ruco L., Peschle C., De Maria R., Identification and expansion of the tumorigenic lung cancer stem cell population. Cell Death and Differentiation 2008 15 3 504 514 2-s2.0-39449088496 10.1038/sj.cdd.4402283 (Pubitemid 351267301)
25. - progenitor cells. Blood 1991 77 6 1218 1227 2-s2.0-0025732159
26. +CD4 4 h i g h metastatic subset in HCT116 colon cancer cells. Clinical and Experimental Metastasis 2011 28 8 751 763 2-s2.0-82355169655 10.1007/s10585-011-9407-7
27. Jaggupilli A., Elkord E., Significance of CD44 and CD24 as cancer stem cell markers: an enduring ambiguity. Clinical and Developmental Immunology 2012 2012 11 10.1155/2012/708036 708036
28. Liu W.-H., Qian N.-S., Li R., Dou K.-F., Replacing Hoechst33342 with Rhodamine123 in isolation of cancer stem-like cells from the MHCC97 cell line. Toxicology in Vitro 2010 24 2 538 545 2-s2.0-76549125931 10.1016/j.tiv.2009.11. 008
29. Adamski D., Mayol J.-F., Platet N., Berger F., Hérodin F., Wion D., Effects of Hoechst 33342 on C2C12 and PC12 cell differentiation. FEBS Letters 2007 581 16 3076 3080 2-s2.0-34250182403 10.1016/j.febslet.2007.05.073 (Pubitemid 46899054)
30. Montanaro F., Liadaki K., Schienda J., Flint A., Gussoni E., Kunkel L. M., Demystifying SP cell purification: viability, yield, and phenotype are defined by isolation parameters. Experimental Cell Research 2004 298 1 144 154 2-s2.0-3042822246 10.1016/j.yexcr.2004.04.010 (Pubitemid 38887314)
31. -cancer cells are similarly tumorigenic. Cancer Research 2005 65 14 6207 6219 2-s2.0-22244433866 10.1158/0008-5472.CAN-05-0592 (Pubitemid 40994406)
32. Yu S.-C., Ping Y.-F., Yi L., Zhou Z.-H., Chen J.-H., Yao X.-H., Gao L., Wang J. M., Bian X.-W., Isolation and characterization of cancer stem cells from a human glioblastoma cell line U87. Cancer Letters 2008 265 1 124 134 2-s2.0-43649086456 10.1016/j.canlet.2008.02.010
33. Hueng D.-Y., Sytwu H.-K., Huang S.-M., Chang C., Ma H.-I., Isolation and characterization of tumor stem-like cells from human meningiomas. Journal of Neuro-Oncology 2011 104 1 45 53 2-s2.0-80052536727 10.1007/s11060-010-0469-1
34. Herreros-Villanueva M., Zhang J., Koenig A., SOX2 promotes dedifferentiation and imparts stem cell-like features to pancreatic cancer cells. Oncogenesis 2013 2 8 e61 10.1038/oncsis.2013.23
35. Wen K., Fu Z., Wu X., Feng J., Chen W., Qian J., Oct-4 is required for an antiapoptotic behavior of chemoresistant colorectal cancer cells enriched for cancer stem cells: effects associated with STAT3/Survivin. Cancer Letters 2013 333 1 56 65 10.1016/j.canlet.2013.01.009
36. Holland J. D., Klaus A., Garratt A. N., Birchmeier W., Wnt signaling in stem and cancer stem cells. Current Opinion in Cell Biology 2013 25 2 254 264 10.1016/j.ceb.2013.01.004
37. Androutsellis-Theotokis A., Leker R. R., Soldner F., Hoeppner D. J., Ravin R., Poser S. W., Rueger M. A., Bae S.-K., Kittappa R., McKay R. D. G., Notch signalling regulates stem cell numbers in vitro and in vivo. Nature 2006 442 7104 823 826 2-s2.0-33747513134 10.1038/nature04940 (Pubitemid 44258913)
38. Liu S., Dontu G., Mantle I. D., Patel S., Ahn N.-S., Jackson K. W., Suri P., Wicha M. S., Hedgehog signaling and Bmi-1 regulate self-renewal of normal and malignant human mammary stem cells. Cancer Research 2006 66 12 6063 6071 2-s2.0-33745728170 10.1158/0008-5472.CAN-06-0054
39. Karamboulas C., Ailles L., Developmental signaling pathways in cancer stem cells of solid tumors. Biochimica et Biophysica Acta 2013 1830 2 2481 2495 10.1016/j.bbagen.2012.11.008